Chemerin regulates β-cell function in mice

Scientific Reports

Volumn 1, Issue , 2011, Pages

  Takahashi, Michiko ^a   Okimura, Yasuhiko ^b   Iguchi, Genzo ^a   Nishizawa, Hitoshi ^a   Yamamoto, Masaaki ^a   Suda, Kentaro ^a   Kitazawa, Riko ^a   Fujimoto, Wakako ^a   Takahashi, Kenichi ^c   Zolotaryov, Fyodor N ^c   Hong, Kyoung Su ^c   Kiyonari, Hiroshi ^d   Abe, Takaya ^d   Kaji, Hidesuke ^e   Kitazawa, Sohei ^f   Kasuga, Masato ^g   Chihara, Kazuo ^a,h   Takahashi, Yutaka ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE WOMEN'S UNIVERSITY   (Japan)

^c JCR Pharmaceuticalc CoLtd   (Japan)

^d RIKEN Center for Biosystems Dynamics Research   (Japan)

^e UNIVERSITY OF HYOGO   (Japan)

^f EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^h Hyogo Prefectural Kakogawa Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMERIN PROTEIN, MOUSE; CHEMOTACTIC FACTOR; CMKLR1 PROTEIN, MOUSE; G PROTEIN COUPLED RECEPTOR; INSULIN; MAFA PROTEIN, MOUSE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR MAF;

ADIPOSE TISSUE; ANIMAL; ARTICLE; C57BL MOUSE; CELL LINE; DRUG ANTAGONISM; GENE SILENCING; GENETICS; GLUCOSE TOLERANCE TEST; KNOCKOUT MOUSE; LIPID DIET; MACROPHAGE; MALE; METABOLISM; MOUSE; PANCREAS ISLET BETA CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); TRANSGENIC MOUSE;

ADIPOSE TISSUE; ANIMALS; CELL LINE; CHEMOTACTIC FACTORS; DIET, HIGH-FAT; GENE KNOCKDOWN TECHNIQUES; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN-SECRETING CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MAF TRANSCRIPTION FACTORS, LARGE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84859623558     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00123     Document Type: Article

References (37)

1. Fantuzzi, G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911-919; quiz 920 (2005).
2. Kershaw, E. E. & Flier, J. S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89, 2548-2556 (2004). (Pubitemid 38766330)
3. Charo, I. F. & Taubman, M. B. Chemokines in the pathogenesis of vascular disease. Circ Res 95, 858-866 (2004). (Pubitemid 39435000)
4. Rossi, D. & Zlotnik, A. The biology of chemokines and their receptors. Annu Rev Immunol 18, 217-242 (2000).
5. Nagpal, S., et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol 109, 91-95 (1997). (Pubitemid 27305655)
6. Wittamer, V., et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. The Journal of experimental medicine 198, 977-985 (2003). (Pubitemid 37248614)
7. Luangsay, S., et al. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J Immunol 183, 6489-6499 (2009).
8. Ernst, M. C. & Sinal, C. J. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab (2010).
9. Zabel, B. A., et al. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. The Journal of experimental medicine 205, 2207-2220 (2008).
10. Barnea, G., et al. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci USA 105, 64-69 (2008).
11. Goralski, K. B., et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. The Journal of biological chemistry 282, 28175-28188 (2007). (Pubitemid 47529521)
12. Bozaoglu, K., et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148, 4687-4694 (2007). (Pubitemid 47481514)
13. Roh, S. G., et al. Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 362, 1013-1018 (2007).
14. Takahashi, M., et al. Chemerin enhances insulin signaling and potentiates insulinstimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett 582, 573-578 (2008).
15. Sell, H., et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58, 2731-2740 (2009).
16. Ernst, M. C., Issa, M., Goralski, K. B. & Sinal, C. J. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 151, 1998-2007 (2010).
17. Ernst, M. C. & Sinal, C. J. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 21, 660-667 (2010).
18. Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627-632 (2008).
19. Zhang, C., et al. MafA is a key regulator of glucose-stimulated insulin secretion. Mol Cell Biol 25, 4969-4976 (2005). (Pubitemid 40781098)
20. Aramata, S., Han, S. I. & Kataoka, K. Roles and regulation of transcription factor MafA in islet β-cells. Endocrine journal 54, 659-666 (2007). (Pubitemid 351377742)
21. Harmon, J. S., Stein, R. & Robertson, R. P. Oxidative stress-mediated, posttranslational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. The Journal of biological chemistry 280, 11107-11113 (2005). (Pubitemid 40418415)
22. Kitamura, Y. I., et al. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell metabolism 2, 153-163 (2005).
23. Wittamer, V., et al. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J Immunol 175, 487-493 (2005). (Pubitemid 40884353)
24. Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11, 85-97 (2011).
25. Kralisch, S., et al. Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept 154, 102-106 (2009).
26. Tateya, S., Tamori, Y., Kawaguchi, T., Kanda, H. & Kasuga, M. An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice. Endocrinology 151, 971-979 (2010).
27. Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M. & Permutt, M. A. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. The Journal of clinical investigation 108, 1631-1638 (2001). (Pubitemid 33144873)
28. Moynihan, K. A., et al. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell metabolism 2, 105-117 (2005).
29. Kishimoto, K., Kitazawa, R., Kurosaka, M., Maeda, S. & Kitazawa, S. Expression profile of genes related to osteoclastogenesis in mouse growth plate and articular cartilage. Histochem Cell Biol 125, 593-602 (2006). (Pubitemid 43673522)
30. Takahashi, M., et al. CXCL14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity. Biochem Biophys Res Commun 364, 1037-1042 (2007). (Pubitemid 350087905)
31. Takahashi, Y., et al. Biologically inactive growth hormone caused by an amino acid substitution. The Journal of clinical investigation 100, 1159-1165 (1997). (Pubitemid 27386300)
32. Shibasaki, T., et al. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci USA 104, 19333-19338 (2007).
33. Miki, T., et al. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes 54, 1056-1063 (2005). (Pubitemid 40446319)
34. Miyazaki, J., et al. Establishment of a pancreatic beta cell line that retains glucoseinducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127, 126-132 (1990). (Pubitemid 20228111)
35. Jazag, A., et al. Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components. Nucleic Acids Res 33, e131 (2005).
36. Morioka, T., et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. The Journal of clinical investigation 117, 2860-2868 (2007). (Pubitemid 47529616)
37. Gunton, J. E., et al. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122, 337-349 (2005). (Pubitemid 41127137)